LY3561774

LY3561774 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY3561774, covering 2025-03-17 to 2025-03-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY3561774 in Participants With Mixed Dyslipidemia [Phase 2]